$53.01
+0 (+0%)
At Close: Jun 23, 2026
Neurocrine to Buy Soleno for $2.9 Billion
07:34am, Monday, 06'th Apr 2026
Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio.
Breakfast News: Soleno Soars 30% On Buyout Talk
07:30am, Monday, 06'th Apr 2026
Neurocrine's reported biotech buy, Coinbase's new regulatory approval, and more
Wall Street Breakfast Podcast: PepsiCo Exits Kanye Fest
07:08am, Monday, 06'th Apr 2026
PepsiCo (PEP) drops sponsorship of a major London music festival after controversy over Kanye West as headliner. Anthropic is being courted by the UK for a London expansion and potential dual listing,
Neurocrine to buy Soleno Therapeutics for $2.9 billion
07:07am, Monday, 06'th Apr 2026
Neurocrine Biosciences will acquire rare disease drugmaker Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday.
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
07:00am, Monday, 06'th Apr 2026
VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative Therapy Expands Neurocrine's High-Growth Comme
Apellis Stock Soars After Biogen Deal, Momentum Score Surges—Here's What Shareholders Get
06:40am, Monday, 06'th Apr 2026
Apellis jumps as Biogen agrees $5.6 Billion acquisition, offering $41/share plus milestones, boosting rare-disease portfolio.
Why Applied Optoelectronics Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
05:19am, Monday, 06'th Apr 2026
Applied Optoelectronics Inc (NASDAQ: AAOI) rose in pre-market trading after securing an 800G transceiver order worth $71 million, bringing total orders from a major customer to $124 million. Other gai
SG Americas Securities LLC Increases Position in Soleno Therapeutics, Inc. $SLNO
05:01am, Monday, 06'th Apr 2026
SG Americas Securities LLC increased its holdings in Soleno Therapeutics, Inc. (NASDAQ: SLNO) by 171.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Comm
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
04:15am, Monday, 06'th Apr 2026
LOS ANGELES, April 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. ("Soleno" or "the Company") (NASDAQ: SLNO) for violations of
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
03:07am, Monday, 06'th Apr 2026
LOS ANGELES, April 6, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Soleno Therapeutics, Inc. ("Soleno"
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
07:18pm, Sunday, 05'th Apr 2026
NEW YORK, April 5, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 a
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options If you purchased or acquired
New York, New York--(Newsfile Corp. - April 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between M
NEW ORLEANS, April 3, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5, 2026 to file lead plaintiff applications in a securities
SLNO INVESTOR ALERT: Soleno (SLNO) Sued After DCCR Launch Setback, Share Drop-- Hagens Berman
06:34pm, Friday, 03'rd Apr 2026
SAN FRANCISCO, April 3, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Soleno Therapeutics, Inc. (NASDAQ: SLNO) seeking to represent investors who purchased Soleno comm
Sign In
Buy SLNO